Melanoma Molecular Diagnostics Market Growth: Opportunities in Liquid Biopsy and AI Integration
The standard of care for melanoma is being redefined by the advent of powerful new diagnostic technologies. Among the most promising are liquid biopsies, offering a less invasive way to monitor disease, and artificial intelligence (AI), which is unlocking new levels of diagnostic accuracy. These innovations are key drivers of Melanoma Molecular Diagnostics Market Growth. With the market...
0 Comments 0 Shares 41 Views